Ronkonkoma, NY, USA, February 3, 2021—Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical industries, is proud to announce that President and CEO Scott Herskovitz has been elected as an at-large board director of the Bio-Process Systems Alliance (BPSA).
The BPSA, an affiliated organization of the Society of Chemical Manufacturers & Affiliates (SOCMA), is an international industry association dedicated to encouraging and accelerating the adoption of single-use manufacturing technologies used in the production of biopharmaceuticals and vaccines. BPSA board members serve staggered two-year terms.
“I am honored to be elected as a BPSA board member and work alongside this highly respected group of industry leaders,” explains Herskovitz. “As a global supplier of single-use medical components, Qosina is committed to supporting the BPSA and their focus on the essential and safe utilization of single-use bioprocessing systems for the production of biopharmaceuticals and critical vaccines.”
Founded in 1980, Qosina is a leading global supplier of OEM single-use components to the medical and pharmaceutical industries. Qosina’s philosophy is to address its customers’ need to reduce time to market by providing thousands of stock components. The company’s vast catalog features more than 5,000 products shown in full-scale illustrations on a one-centimeter grid. Qosina offers free samples of most items, low minimum order requirements, just-in-time delivery, modification of existing molds, and new product design and development. Qosina is ISO 13485, ISO 9001, ISO 22301 and ISO 14001 certified, and operates in a 95,000 square-foot facility with an ISO Class 8 Clean Room. To learn about Qosina’s full component offering, which includes the newest products, visit www.qosina.com or call +1 (631) 242-3000. Visit Qosmedix, Qosina’s cosmetics division, at www.qosmedix.com. Qosmedix is a certified global supplier of beauty tools and accessories to the cosmetic, skincare, spa and salon industries.